The study of genes and that of immune therapy comprise the two most exciting areas present research is focused on. This research is being conducted by all entities involved in cancer research i.e. Pharma Industry, NCI, NIH, etc. In fact, as far as I know, there is not much in the pipeline for new chemo agents benefitting our patient community. Immune research has shown positive tumor responses for our cancer also and that rare cancers such as ours (solid tumors) have a higher probability of inclusion in present research. As you may know, CC research historically lacked the necessary funding to propel interest in this disease, but I strongly believe that with the present developments, we may finally reap some benefits too.
THIS INFORMATION IS NOT INTENDED NOR IMPLIED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE. YOU SHOULD ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROVIDER